P38 mitogen-activated protein kinase activity is required during mitosis for timely satisfaction of the mitotic checkpoint but not for the fidelity of chromosome segregation.
Although p38 activity is reported to be required as cells enter mitosis for proper spindle assembly and checkpoint function, its role during the division process remains controversial in lieu of direct data. We therefore conducted live cell studies to determine the effect on mitosis of inhibiting or depleting p38. We found that in the absence of p38 activity the duration of mitosis is prolonged by approximately 40% in nontransformed human RPE-1, approximately 80% in PtK2 (rat kangaroo), and approximately 25% in mouse cells, and this prolongation leads to an elevated mitotic index. However, under this condition chromatid segregation and cytokinesis are normal. Using Mad2/YFP-expressing cells, we show the prolongation of mitosis in the absence of p38 activity is directly due to a delay in satisfying the mitotic checkpoint. Inhibiting p38 did not affect the rate of chromosome motion; however, it did lead to the formation of significantly (10%) longer metaphase spindles. From these data we conclude that normal p38 activity is required for the timely stable attachment of all kinetochores to spindle microtubules, but not for the fidelity of the mitotic process. We speculate that p38 activity promotes timely checkpoint satisfaction by indirectly influencing those motor proteins (e.g., Klp10, Klp67A) involved in regulating the dynamics of kinetochore microtubule ends.
Lee
Kyunghee
K
Division of Translational Medicine, Wadsworth Center, Albany, NY 12201-0509, USA.
Kenny
Alison E
AE
Rieder
Conly L
CL
D000818:Animals; D001324:Autoantigens / Q000235:genetics / Q000378:metabolism; D002460:Cell Line; D000076247:Centromere Protein A; D018385:Centrosome / Q000378:metabolism; D002868:Chromosomal Proteins, Non-Histone / Q000235:genetics / Q000378:metabolism; D020090:Chromosome Segregation; D006801:Humans; D018386:Kinetochores / Q000378:metabolism; D051379:Mice; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism; D008938:Mitosis / Q000502:physiology*; D015739:Nocodazole / Q000494:pharmacology; D048328:Potoroidae; D034622:RNA Interference; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D050257:Tubulin Modulators / Q000494:pharmacology; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
D001324:Autoantigens; D000076247:Centromere Protein A; D002868:Chromosomal Proteins, Non-Histone; D011993:Recombinant Fusion Proteins; D050257:Tubulin Modulators; D048051:p38 Mitogen-Activated Protein Kinases; D015739:Nocodazole
J Cell Sci. 1993 Jan;104 ( Pt 1):125-37
8383693
Carcinogenesis. 2002 Nov;23(11):1831-8
12419831
J Immunol. 2006 Aug 1;177(3):1913-7
16849504
Genes Dev. 2003 Aug 15;17(16):1969-78
12893778
Nat Cell Biol. 2007 Feb;9(2):160-70
17330329
J Cell Sci. 2004 Jul 15;117(Pt 16):3669-77
15252134
J Biol. 2009;8(10):88
19930621
Cell Cycle. 2005 Jan;4(1):57-62
15611649
Mol Biol Cell. 2001 Jul;12(7):1995-2009
11451998
J Biol Chem. 1995 Mar 31;270(13):7420-6
7535770
J Exp Med. 2000 Jan 17;191(2):321-34
10637276
J Biol Chem. 2007 Aug 3;282(31):22984-92
17548358
Genes Dev. 2007 Sep 1;21(17):2205-19
17785528
Methods. 2006 Jan;38(1):2-16
16343936
J Cell Sci. 1996 May;109 ( Pt 5):1081-93
8743955
Trends Mol Med. 2009 Aug;15(8):369-79
19665431
Mol Cell Biol. 1999 May;19(5):3857-68
10207109
Science. 1994 Aug 5;265(5173):808-11
7914033
Mol Cancer Ther. 2004 Jun;3(6):661-9
15210851
J Cell Biol. 2004 Aug 16;166(4):517-26
15302851
J Cell Biol. 2004 Aug 16;166(4):507-16
15302856
Oncogene. 2008 Nov 6;27(52):6635-45
18695677
Genes Dev. 1995 Sep 1;9(17):2117-30
7657164
J Biol Chem. 1996 Jul 26;271(30):17920-6
8663524
Oncogene. 2001 Jan 11;20(2):147-55
11313944
Nature. 2001 May 3;411(6833):102-7
11333986
Curr Biol. 1998 Sep 24;8(19):1049-57
9768359
Cell Cycle. 2005 Nov;4(11):1616-24
16258274
Curr Biol. 2009 Dec 1;19(22):1937-42
19879145
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15546-51
17032753
Science. 1998 Apr 24;280(5363):599-602
9554853
Mol Cell. 2000 Jul;6(1):109-16
10949032
Curr Biol. 2009 Jul 14;19(13):1086-95
19540117
J Cell Physiol. 2010 May;223(2):327-34
20054826
Cell Cycle. 2007 Jun 15;6(12):1487-95
17582224
Biochem J. 2000 Oct 1;351(Pt 1):95-105
10998351
Cell Mol Life Sci. 2010 Jan;67(2):321-33
19915797
Curr Biol. 2005 Nov 22;15(22):1979-88
16303556
Science. 1993 Mar 19;259(5102):1760-3
7681220
Mol Immunol. 2003 Mar;39(13):815-27
12617997
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6353-8
17395714
Cell. 1994 Sep 23;78(6):1027-37
7923353
J Cell Sci. 2005 Jan 15;118(Pt 2):397-408
15632108
Nature. 2004 Jan 22;427(6972):364-70
14681690
Cell Motil Cytoskeleton. 2009 Aug;66(8):437-47
18792104
Mol Cell Biol. 2007 Jan;27(1):170-81
17030606
Mol Biol Cell. 2003 May;14(5):2071-87
12802076
Neuroscience. 2002;112(3):583-91
12074900
Curr Opin Genet Dev. 2002 Feb;12(1):92-7
11790561
Cancer Res. 2004 Apr 1;64(7):2502-8
15059905
J Cell Biol. 2009 Sep 7;186(5):675-84
19720871